Tag: Acquisition of DiabTec
Mubadala’s KELIX bio completes acquisition of DiabTec
KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar.
This acquisition...